Posted by Michael Wonder on 30 Aug 2023
Medicare should negotiate with drug makers. But not set prices.
30 August 2023 - New rules in America threaten to deter innovation.
A quirk of American law long barred Medicare, the public-health insurer for the elderly, from negotiating with drug firms over prices.
